{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:04:43Z","timestamp":1793649883506,"version":"4.5.1"},"reference-count":33,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Ophthalmology"],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>This study aimed to assess the influence of vitreoretinal interface (VRI) on the outcome of Brolucizumab intravitreal injections (IVBr) in patients with age-related macular neovascularization (MNV).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>40 eyes of 40 patients with active-naive MNV candidates to IVBr were enrolled at the Ophthalmology Clinic of the University \u201cG. d\u2019Annunzio,\u201d Chieti-Pescara, Italy. Based on the VRI condition, 20 patients were included in the G0 group (without evidence of VRI alterations), whereas 20 patients were enrolled in the G1 group (with VRI abnormalities). The primary outcome measures were changes in best-corrected visual acuity (BCVA), central macular thickness (CMT), subfoveal choroidal thickness (SCT), pigment epithelial detachment presence and maximum height (PEDMH), intraretinal fluid (IRF) presence, subfoveal subretinal fluid (SSRF) presence and thickness (SSRFT), subretinal pigment epithelium fluid (SRPEF) presence and SRPEF thickness (SRPEFT).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      There were no significant differences in BCVA and SCT between the two groups, although both parameters significantly changed over time (BCVA p 0.005; SCT\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). No differences in CMT and PEDMH were found between the two groups. SSRF presence showed differences between the two groups at T4 (p 0.044), and IRF presence showed significant differences over time (p 0.008) in favor of MNV eyes without VRI alterations.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Concomitant vitreomacular interface disease alterations in eyes treated with IVBr for MNV influenced fluid presence with greater persistence of SSRF and IRF compared to MNV eyes without VRI. Nevertheless, the overall macular thickness and visual function were not significantly different between the two groups.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/11206721241282429","type":"journal-article","created":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T07:27:24Z","timestamp":1726558044000},"page":"1005-1012","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":7,"title":["Impact of vitreomacular interface on intravitreal Brolucizumab efficacy in age-related macular neovascularization"],"prefix":"10.1177","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5856-6686","authenticated-orcid":false,"given":"Maria Ludovica","family":"Ruggeri","sequence":"first","affiliation":[{"name":"Ophthalmology Clinic, Department of Medicine and Science of Ageing, D\u2019Annunzio University of Chieti-Pescara, Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Toto","sequence":"additional","affiliation":[{"name":"Ophthalmology Clinic, Department of Medicine and Science of Ageing, D\u2019Annunzio University of Chieti-Pescara, Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucio","family":"Zeppa","sequence":"additional","affiliation":[{"name":"AORN San Giuseppe Moscati Hospital, Avellino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Gironi","sequence":"additional","affiliation":[{"name":"Ophthalmology Clinic, Department of Medicine and Science of Ageing, D\u2019Annunzio University of Chieti-Pescara, Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0818-6124","authenticated-orcid":false,"given":"Alberto","family":"Quarta","sequence":"additional","affiliation":[{"name":"Ophthalmology Clinic, Department of Medicine and Science of Ageing, D\u2019Annunzio University of Chieti-Pescara, Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizio","family":"Venturoni","sequence":"additional","affiliation":[{"name":"Ophthalmology Clinic, Department of Medicine and Science of Ageing, D\u2019Annunzio University of Chieti-Pescara, Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agbeanda","family":"Aharrh-Gnama","sequence":"additional","affiliation":[{"name":"Ophthalmology Clinic, Department of Medicine and Science of Ageing, D\u2019Annunzio University of Chieti-Pescara, Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3278-1561","authenticated-orcid":false,"given":"Annamaria","family":"Porreca","sequence":"additional","affiliation":[{"name":"Department of Medical, Oral and Biotechnological Sciences, Laboratory of Biostatistics, D\u2019Annunzio University of Chieti-Pescara, Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Di Nicola","sequence":"additional","affiliation":[{"name":"Department of Medical, Oral and Biotechnological Sciences, Laboratory of Biostatistics, D\u2019Annunzio University of Chieti-Pescara, Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo","family":"Mastropasqua","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Imaging and Clinical Sciences, University \u201cG. d\u2019Annunzio\u201d Chieti-Pescara, Chieti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2024,9,16]]},"reference":[{"key":"e_1_3_3_2_2","first-page":"35","article-title":"Vitreopapillary adhesion in macular diseases","volume":"107","author":"Sebag J","year":"2009","unstructured":"Sebag J, Wang MY, Nguyen D, et al. Vitreopapillary adhesion in macular diseases. Trans Am Ophthalmol Soc 2009; 107: 35\u201344.","journal-title":"Trans Am Ophthalmol Soc"},{"key":"e_1_3_3_3_2","article-title":"Role of the vitreous in retinal pathology: a narrative review","volume":"15","author":"Popescu S-I","year":"2023","unstructured":"Popescu S-I, Munteanu M, Patoni C, et al. Role of the vitreous in retinal pathology: a narrative review. Cureus 2023; 15: e43990.","journal-title":"Cureus"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(13)70145-1"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2023.2222545"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2019.04.017"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1159\/000534894"},{"key":"e_1_3_3_8_2","article-title":"Brolucizumab intravitreal injection in macular neovascularization Type 1: VA, SD-OCT and OCTA parameters changes during a 16-weeks follow up","author":"Toto L","year":"2022","unstructured":"Toto L, Ruggeri ML, D\u2019Aloisio R, et al. Brolucizumab intravitreal injection in macular neovascularization Type 1: VA, SD-OCT and OCTA parameters changes during a 16-weeks follow up. Ophthalmic Res 2022. https:\/\/doi.org\/10.1159\/000526851","journal-title":"Ophthalmic Res"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S231913"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.117.246249"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.072876"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-30146-5"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2023.04.012"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40123-023-00701-4"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.64.15.25"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-018-4009-6"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-022-02640-3"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10384-022-00969-2"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2021.1952979"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2012.07.004"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1110823"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1159\/000521975"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2015.09.032"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-013-9884-6"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-019-1087-0"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000009345"},{"key":"e_1_3_3_27_2","article-title":"Relationship between Variations in Posterior Vitreous Detachment and Visual Prognosis in Idiopathic Epiretinal Membranes","volume":"7","author":"Ota A","year":"2015","unstructured":"Ota A, Tanaka Y, Toyoda F, et al. Relationship between Variations in Posterior Vitreous Detachment and Visual Prognosis in Idiopathic Epiretinal Membranes. Clinical Ophthalmology 2015; 7. https:\/\/doi.org\/10.2147\/opth.s89683","journal-title":"Clinical Ophthalmology"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.24976\/Discov.Med.202335179.93"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2010.04.015"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000003594"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pdpdt.2023.103555"},{"key":"e_1_3_3_32_2","first-page":"1951","article-title":"The influence of vitreomacular adhesion on outcomes after aflibercept therapy for neovascular age-related macular degeneration","volume":"35","author":"McKibbin M","year":"2015","unstructured":"McKibbin M, Suter CA, Willis T. The influence of vitreomacular adhesion on outcomes after aflibercept therapy for neovascular age-related macular degeneration. Retina-The Journal of Retinal and Vitreous Diseases 2015; 35: 1951\u20131956.","journal-title":"Retina-The Journal of Retinal and Vitreous Diseases"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2015.04.028"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40942-021-00342-4"}],"container-title":["European Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/11206721241282429","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/11206721241282429","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/11206721241282429","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T19:46:46Z","timestamp":1777405606000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/11206721241282429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,16]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["10.1177\/11206721241282429"],"URL":"https:\/\/doi.org\/10.1177\/11206721241282429","relation":{},"ISSN":["1120-6721","1724-6016"],"issn-type":[{"value":"1120-6721","type":"print"},{"value":"1724-6016","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,16]]}}}